Nikolaos T. Liakounakos
Vorsitzender bei EUROMEDICA S.A.
Ursprung des Netzwerks ersten Grades von Nikolaos T. Liakounakos
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Hospital/Nursing Management | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nikolaos T. Liakounakos
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Pittsburgh | College/University | Graduate Degree Masters Business Admin | |
| AXON HOLDINGS S.A. | Medical/Nursing Services | Investor Relations Contact Director/Board Member | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Director/Board Member | |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Medical Specialties | Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree | |
| BIOVENTUS INC. | Medical Specialties | Director/Board Member | |
Flowonix Medical, Inc.
 Flowonix Medical, Inc. Medical SpecialtiesHealth Technology Flowonix Medical, Inc. designs and develops proprietary implantable pumps. It provides implantable intrathecal pumps to help manage chronic pain for cancer patients and patients with back pain. The company was founded in 2005 and is headquartered in Mt. Olive, NJ. | Medical Specialties | Director/Board Member | |
| VIRBAC | Biotechnology | Director/Board Member | |
| Cyrille Petit Conseil SAS | Chairman | ||
| Blue Earth Diagnostics, Inc. | Director/Board Member | ||
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Goldman Sachs Ltd.
 Goldman Sachs Ltd. Regional BanksFinance Part of The Goldman Sachs Group, Inc., Goldman Sachs Ltd. is an international merchant banking business. The company is based in London, UK. The CEOs of the British company are Philippe Louis Hubert Camu, Natasha Jhunjhunwala, Marie Lennon, Helen Moloney. | Regional Banks | Corporate Officer/Principal | |
| POLAREAN IMAGING PLC | Medical Specialties | Director/Board Member | |
Bracco Horizons Ltd.
 Bracco Horizons Ltd. BiotechnologyHealth Technology Founded in 2019, Bracco Horizons Ltd. is a British biotechnology company that engages in research and development of biotechnology products. Part of Bracco SpA, the company is based in Oxford, UK. | Biotechnology | Director/Board Member | |
| Aristotle University of Thessaloniki | College/University | Undergraduate Degree | |
| University of Patras | College/University | Undergraduate Degree | |
| University of London | College/University | Graduate Degree | |
| Euromedica General Clinic of Dodecanese | Chief Executive Officer | ||
| ELLAKTOR S.A. | Engineering & Construction | Director/Board Member | |
| GE Capital Americas | Financial Conglomerates | Corporate Officer/Principal | |
BNP Paribas (New York Branch)
 BNP Paribas (New York Branch) Regional BanksFinance BNP Paribas operates as an investment advisor. It provides capital markets, securities services, financing, treasury and advisory solutions. The firm’s services are provided via four core business lines: Global Markets, Securities Services, Financing Solutions and Advisory. The company is headquartered in New York, NY. | Regional Banks | Corporate Officer/Principal | |
| SEANERGY MARITIME HOLDINGS CORP. | Marine Shipping | Director of Finance/CFO | |
| Indiana University | College/University | Undergraduate Degree | |
| University of Sussex | College/University | Undergraduate Degree | |
| City University London | College/University | Graduate Degree | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Target Discovery, Inc.
 Target Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Target Discovery, Inc. provides scientific research services. It discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and the management of diseases. The firm’s products address prostate cancer aggressiveness, and chemotherapy selection in breast and ovarian cancer. The company was founded by Luke V. Schneider in 1999 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| The University of Chicago | College/University | Masters Business Admin | |
Bioventus LLC
 Bioventus LLC Medical SpecialtiesHealth Technology Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| Biopharm Physicians LLC | Founder | ||
Farallon Capital Europe LLP
 Farallon Capital Europe LLP Investment ManagersFinance Farallon Capital Europe LLP (Farallon Europe) is an independent Great Britain-based alternative investment firm which was founded in 2004 by Farallon Capital International Ltd., Andrew Spokes and Nicolas Giauque. Formerly known as Noonday Asset Management LLP, the firm changed their name to Farallon Capital Europe in 2013. Farallon Europe is headquartered in London and provides investment advice to the Farallon Funds, including separately managed accounts for institutions such as endowments, foundations, charitable organizations and state and municipal government entities. | Investment Managers | Analyst-Fixed Income | |
| MERMEREN KOMBINAT AD | Construction Materials | Director/Board Member | |
| TRASTOR REAL ESTATE INVESTMENT COMPANY SA | Real Estate Investment Trusts | Director/Board Member | |
| University of Birmingham | College/University | Undergraduate Degree | |
| ATTICA HOLDINGS S.A. | Marine Shipping | Director/Board Member | |
| SMITH & NEPHEW PLC | Medical Specialties | Corporate Officer/Principal | |
Hellenic Financial Stability Fund
 Hellenic Financial Stability Fund Financial ConglomeratesFinance Hellenic Financial Stability Fund is a Greek government-controlled financial institution founded in 2010 with the mission to maintain the stability of the Greek banking system. The fund operates on a structured and clear roles framework, with a general council consisting of seven non-executive members and an executive committee of three members. The HFSF investment relations program aims to provide transparent and coherent information to the investment community, organizations, and media in an appropriate, timely, and fair manner. Ultimately, the Hellenic Financial Stability Fund is controlled by the Government of Greece. | Financial Conglomerates | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 18 |
| Griechenland | 11 |
| Vereinigtes Königreich | 11 |
| Frankreich | 4 |
| Dänemark | 2 |
Sektoral
| Consumer Services | 11 |
| Health Technology | 11 |
| Finance | 7 |
| Health Services | 4 |
| Transportation | 4 |
Operativ
| Director/Board Member | 28 |
| Corporate Officer/Principal | 9 |
| Undergraduate Degree | 6 |
| Chief Executive Officer | 4 |
| Independent Dir/Board Member | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nikolaos T. Liakounakos
- Unternehmensverbindungen
